204
G. Prakash et al. / Inorganica Chimica Acta 427 (2015) 203–210
In the present work, we reacted the 1,3,4-oxadiazoles (A–C)
(Calc.)] for C14H11N3O3: C, 62.17 (67.45); H, 4.39 (4.12); N, 15.52
(15.61)%.
derived from isoniazid and salicylaldehydes with ruthenium(II)
precursors in the presence of NaOH, with the aim of producing
Ru(II) complexes bearing oxadiazoles. Surprisingly, we observed
the formation of Ru(II) N,N0-bishydrazone complexes (1–3). As a
part of our continuous research on utilizing new transition metal
complexes for various catalytic applications, herein we have
reported an alternative pathway for the synthesis of ruthenium(II)
bis(salicylidene) complexes (1–3) and their versatile catalytic
activity in the N-alkylation of amines with alcohols.
2.3. Synthesis and characterization of Ru(II) complexes
The oxadiazole compound (A–C) was dissolved in methanol and
added 1 mL of methanolic NaOH solution and stirred at room tem-
perature for 30 min. To this, an equimolar quantity of precursor
complex [RuHCl(CO)(PPh3)3] dissolved in methanol was added
and refluxed with stirring for 3 h. Then the reaction mixture was
filtered and kept at room temperature for 48 h to obtain reddish
crystals of Ru(II) hydrazone complexes. The spectral and elemental
data obtained for complex 1 are in good agreement with that of
similar reported complex, which has been synthesized by the reac-
tion of [RuHCl(CO)(PPh3)3] with N,N0-bis(salicylidene)hydrazine in
methanol in presence of KOH [15c].
2. Experimental
2.1. Materials and methods
The chemicals of AR grade were purchased commercially and
used without further purification. The precursor complex
[RuHCl(CO)(PPh3)3] was prepared based on the literature proce-
dure [16]. Elemental analyses of carbon, hydrogen and nitrogen
were carried out using a Vario EL III elemental analyzer. The IR
spectra were obtained as KBr pellets on a Nicolet Avatar model
spectrophotometer in the range of 4000–400 cmꢀ1. Electronic
spectra were recorded using a Shimadzu UV-1650 PC spectropho-
tometer in 800–200 nm range. The 1H and 13C NMR spectral anal-
yses were performed on Bruker Avance III instrument using TMS as
internal standards. GC-Mass spectral studies were carried out on
JEOL GCMATE II mass spectrometer. Melting points were checked
using the Technico micro heating table and are uncorrected.
2.3.1. Ruthenium(II) bis(5-chlorosalicylidene)hydrazone complex (2)
Reddish orange; Yield: 76%. M.p.: 241 °C. UV–Vis (CH2Cl2,
kmax/nm,
(1636), 452 (22,824). FT-IR (KBr,
e
max/ dm3molꢀ1 cmꢀ1): 249 (36,282), 270 (28,462), 340
m
cmꢀ1): 3339 (OAH), 1672
(C@N1), 1597 (C@N2), 1512 (CAO), 1540 (C@C). 1H NMR (CDCl3,
ppm): 12.03 (s, 1H, OH), 8.74 (s, H, CH@N1), 9.31 (s, 1H, CH@N2),
7.11–7.48 (m, 8H, Ar), 7.73–7.96 (m, PPh3-H, 30H), ꢀ6.82 (d, Ru-
H, 1H). 13C NMR (DMSO-d6, ppm): 206.32 (C„O), 168.83
(C@NARu), 163.76 (C@N), 159.00 (CAO), 135.12 (Ar-C), 134.65
(Ar-C), 134.58 (Ar-C), 134.36 (Ar-C), 134.28 (Ar-C), 134.20 (Ar-C),
133.65 (Ar-C), 132.46 (Ar-C), 132.16 (Ar-C), 129.52 (Ar-C), 128.01
(Ar-C), 127.95 (Ar-C), 127.89 (Ar-C), 124.18 (Ar-C), 119.32 (Ar-C),
118.28 (Ar-C), 117.38 (Ar-C); Anal. [Found (Calc.)] for C51H40N2O3
P2Cl2Ru: C, 63.77 (63.62); H, 4.36 (4.19); N, 2.74 (2.91)%.
2.2. Preparation of oxadiazole compounds (A–C)
The oxadiazole compounds A–C were prepared from isoniazid
and salicylaldehydes in a three stage reaction according to the lit-
erature methods [17]. The products were recrystallized from etha-
nol at 60 °C. The detailed general procedure for the preparation of
oxadiazoles is given in Scheme S1, ESI.
2.3.2. Ruthenium(II) bis(3-methoxysalicylidene)hydrazone complex
(3)
Red; Yield: 73%. M.p.: 268 °C. UV–Vis (CH2Cl2, kmax/nm,
e
max/dm3 molꢀ1 cmꢀ1): 251 (32772), 284 (26123), 342 (1232),
465 (18365). FT-IR (KBr,
m
cmꢀ1): 3271 (OH), 1646 (C@N1), 1604
(C@N2), 1496 (CAO), 1550 (C@C). 1H NMR (CDCl3, ppm): 11.34
(s, 1H, OH), 8.55 (s, H, CH@N1), 8.79 (s, 1H, CH@N2), 6.91–7.24
(m, 8H, Ar), 7.40–7.86 (m, PPh3-H, 30H), 3.30, 2.62 (s, 1H each,
OCH3), ꢀ6.04 (d, Ru-H, 1H). 13C NMR (DMSO-d6, ppm): 203.90
(C„O), 167.23 (C@N-Ru), 158.51 (C@N), 149.86 (ArCAO), 134.30
(Ar-C), 133.24 (Ar-C), 133.16 (Ar-C), 132.71 (Ar-C), 130.40 (Ar-C),
130.17 (Ar-C), 130.07 (Ar-C), 129.63 (Ar-C), 128.91 (Ar-C), 128.79
(Ar-C), 128.56 (Ar-C); Anal. [Found (Calc.)] for C53H46N2O5P2Ru:
C, 66.92 (66.73); H, 4.97 (4.86); N, 2.68 (2.94)%.
2.2.1. 2-(5-Pyridine-4-yl-[1,3,4]oxadiazol-2-yl)-phenol (A)
Compound A was prepared from isonicotinic acid hydrazide
(1.4 g, 10 mmol) and salicylaldehyde (1.6 mL, 11 mmol). Yellow;
Yield: 78%. M.p.: 220 °C. UV–Vis (CH3OH, kmax, nm): 257, 291. IR
(KBr,
m
cmꢀ1): 3399 (OH), 1678 (C@N), 1384 (CAO), 1546 (Aro-
matic C@C). 1H NMR (CDCl3, ppm): 10.92 (s, 1H, OH), 6.98–7.71
(m, 4H, Ar), 7.82 (d, 2H, Py), 8.10 (d, 2H, Py). GC–MS: 239.40
[M]+. Anal. [Found (Calc.)] for C13H9N3O2: C, 65.04 (65.27); H,
3.84 (3.79); N, 17.71 (17.56)%.
2.4. X-ray crystallography
2.2.2. 4-Chloro-2-(5-pyridine-4-yl-[1,3,4]oxadiazol-2-yl)-phenol (B)
Compound B was synthesized from isonicotinic acid hydrazide
(1.4 g, 10 mmol) and 5-chlorosalicylaldehyde (1.7 g, 11 mmol).
Crystals of the complexes 1 and 2 were mounted on glass fibers
and used for data collection. Crystal data were collected at 295(2) K
using a Gemini A Ultra Oxford Diffraction automatic diffractome-
Yellow; Yield: 83%. M.p.: 178 °C. UV–Vis (CH2Cl2, kmax/nm, emax
/
dm3 molꢀ1 cmꢀ1): 242 (26424), 288 (22236). (KBr,
m
cmꢀ1): 3457
ter. Graphite monochromated Mo K
a radiation (k = 0.71073 Å)
(OH), 1680 (C@N), 1345 (CAO), 1445 (C@C). 1H NMR (CDCl3,
ppm): 11.05 (s, 1H, OH), 6.82–7.52 (m, 3H, Ar), 7.80 (d, 2H, Py),
8.10 (d, 2H, Py). GC–MS: 275.04 [M+H]+. Anal. [Found (Calc.)] for
was used throughout. The absorption corrections were performed
by the multi-scan method. Corrections were made for Lorentz
and polarization effects. The structures were solved by direct
methods using the program SHELXS. Refinement and all further cal-
culations were carried out using SHELXL-97 [18]. The H atoms were
included in calculated positions and treated as riding atoms using
the SHELXL default parameters. The non-hydrogen atoms were
refined anisotropically, using weighted full-matrix least squares
on F2. Atomic scattering factors were incorporated in the computer
programs. In the solid state of complex 2, a disorder is observed
within the two different enantiomeric forms in such a manner that
only the CAO group and hydrogen atom shared the ligand position
mutually.
C13H8ClN3O2: C, 56.97 (57.05); H, 2.87 (2.95); N, 15.52 (5.35)%.
2.2.3. 2-Methoxy-6-(5-pyridine-4-yl-[1,3,4]oxadiazol-2-yl)-phenol (C)
Compound C was synthesized from isonicotinic acid hydrazide
(1.4 g, 10 mmol) and o-vanillin (1.67 g, 11 mmol). Yellow; Yield:
68%. M.p.: 276 °C. UV–Vis (CH2Cl2, kmax/nm,
e
max/dm3 molꢀ1
m
cmꢀ1): 3458 (OH),
-
cmꢀ1): 246 (28256), 306 (19743). IR (KBr,
1674 (C@N), 1371 (CAO), 1514 (C@C).1H NMR (CDCl3, ppm):
10.25 (s, 1H, OH), 6.65–7.13 (m, 3H, Ar), 7.20 (d, 2H, Py), 7.72 (d,
2H, Py), 3.35 (s, 3H, OCH3). GC–MS: 269.13 [M]+. Anal. [Found